SE9403055D0 - A new human peptide antibiotic (FALL-39) and its use - Google Patents
A new human peptide antibiotic (FALL-39) and its useInfo
- Publication number
- SE9403055D0 SE9403055D0 SE9403055A SE9403055A SE9403055D0 SE 9403055 D0 SE9403055 D0 SE 9403055D0 SE 9403055 A SE9403055 A SE 9403055A SE 9403055 A SE9403055 A SE 9403055A SE 9403055 D0 SE9403055 D0 SE 9403055D0
- Authority
- SE
- Sweden
- Prior art keywords
- fall
- new human
- human peptide
- peptide antibiotic
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
New polypeptides comprising the following amino acid sequence: E K I G K E F K R I V O R I K D F L R N L V, and functional derivatives and pharmaceutically acceptable salts thereof; pharmaceutical composition containing such polypeptides as active ingredients; a method for inhibiting microbial growth in animals including man; and a cDNA sequence capable of expressing a precursor protein to such polypeptide.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9403055A SE9403055L (en) | 1994-09-13 | 1994-09-13 | New human peptide antibiotic (case-39) and its use |
AU35368/95A AU3536895A (en) | 1994-09-13 | 1995-09-12 | A new human peptide antibiotic (fall-39) and its use |
PCT/SE1995/001030 WO1996008508A1 (en) | 1994-09-13 | 1995-09-12 | A new human peptide antibiotic (fall-39) and its use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9403055A SE9403055L (en) | 1994-09-13 | 1994-09-13 | New human peptide antibiotic (case-39) and its use |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9403055D0 true SE9403055D0 (en) | 1994-09-13 |
SE9403055L SE9403055L (en) | 1996-03-14 |
Family
ID=20395220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9403055A SE9403055L (en) | 1994-09-13 | 1994-09-13 | New human peptide antibiotic (case-39) and its use |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3536895A (en) |
SE (1) | SE9403055L (en) |
WO (1) | WO1996008508A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030022829A1 (en) * | 2001-03-30 | 2003-01-30 | Wendy Maury | Novel antiviral activities primate theta defensins and mammalian cathelicidins |
WO2002095076A2 (en) * | 2001-05-23 | 2002-11-28 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Modified polypeptides having protease-resistance and/or protease-sensitivity |
WO2003039443A2 (en) * | 2001-11-05 | 2003-05-15 | Deutsches Krebsforschungszentrum | Novel genetic markers for leukemias |
SE0300207D0 (en) | 2003-01-29 | 2003-01-29 | Karolinska Innovations Ab | New use and composition |
US7777000B2 (en) | 2003-03-06 | 2010-08-17 | The Regents Of The University Of California | Anti-viral activity of cathelicidin peptides |
US7173007B1 (en) * | 2003-04-02 | 2007-02-06 | The Regents Of The University Of California | Therapy for microbial infections |
CN1878789A (en) | 2003-10-21 | 2006-12-13 | 加利福尼亚大学董事会 | Human cathelicidin antimicrobial peptides |
US7776823B2 (en) | 2003-10-21 | 2010-08-17 | The Regents Of The University Of California | Human cathelicidin antimicrobial peptides |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4674511A (en) * | 1979-04-30 | 1987-06-23 | American Hospital Supply Corporation | Medical electrode |
US5095916A (en) * | 1985-06-20 | 1992-03-17 | Medtronic, Inc. | Cardioversion and defibrillation lead system |
EP0416159B1 (en) * | 1989-09-07 | 1995-05-24 | Siemens Aktiengesellschaft | Adhesive electrode pad for a HF surgical apparatus |
US5063932A (en) * | 1989-10-03 | 1991-11-12 | Mieczyslaw Mirowski | Controlled discharge defibrillation electrode |
-
1994
- 1994-09-13 SE SE9403055A patent/SE9403055L/en not_active Application Discontinuation
-
1995
- 1995-09-12 AU AU35368/95A patent/AU3536895A/en not_active Abandoned
- 1995-09-12 WO PCT/SE1995/001030 patent/WO1996008508A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
SE9403055L (en) | 1996-03-14 |
AU3536895A (en) | 1996-03-29 |
WO1996008508A1 (en) | 1996-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1077070A3 (en) | Oral drug delivery compositions | |
RS49707B (en) | Application of a polypeptide analog of parathyroid hormone related peptide (pthrp) and salts thereof for the preparation of a medicament for the treatment of bone healing | |
ATE125869T1 (en) | GROWTH HORMONE FUSION PROTEINS. | |
HUP0000589A2 (en) | Aqueous formulations of peptides | |
WO1996024370B1 (en) | Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin | |
SE9101838D0 (en) | NOVEL PEPTIDES AND THEIR USE | |
SE9403055D0 (en) | A new human peptide antibiotic (FALL-39) and its use | |
AU4363199A (en) | Use of hmg proteins for the preparation of medicaments having cytotoxic activity | |
SE9604593D0 (en) | Antimicrobially active polypeptides | |
WO2002096467A3 (en) | Pharmaceutical use for secreted bacterial effector proteins | |
KR927002373A (en) | Polypeptide Compounds Having Growth Hormone Secretion Activity | |
DE3777845D1 (en) | PHARMACEUTICAL SUBSTANCE FOR THE TREATMENT OF MYELOGENIC LEUKAEMIA. | |
CA2071757A1 (en) | Implant compositions containing a biologically active protein, peptide or polypeptide | |
MY129946A (en) | Compound with gastric acid inhibitory effect and process for its preparation. | |
MY103251A (en) | Biologically active molecules | |
KR900005994A (en) | Pharmaceutical preparations for the treatment of diseases caused by thrombocytopenia or thrombocytopenia | |
EP0561877A4 (en) | ||
ATE3416T1 (en) | PHARMACOLOGICALLY ACTIVE PEPTIDES AND MEDICATIONS CONTAINING THEM. | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
EP1074264A4 (en) | Neovascularization inhibitors | |
PL355852A1 (en) | Fragments of virus protein vp2 or 3 of the polyoma virus, used for transporting active ingredients | |
SE9401480L (en) | A new 78-residue polypeptide (NK-lysine) and its use | |
AU637589B2 (en) | Ancrod proteins, their production and use | |
KR950704358A (en) | Cathepsin L specific inhibitory polypeptide | |
SE9904132D0 (en) | Pharmaceutical composition for treatment of diarrhea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 9403055-8 |